IL77694A - Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging - Google Patents

Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging

Info

Publication number
IL77694A
IL77694A IL77694A IL7769486A IL77694A IL 77694 A IL77694 A IL 77694A IL 77694 A IL77694 A IL 77694A IL 7769486 A IL7769486 A IL 7769486A IL 77694 A IL77694 A IL 77694A
Authority
IL
Israel
Prior art keywords
canine parvovirus
viruses
cell culture
derived therefrom
additional cell
Prior art date
Application number
IL77694A
Other languages
English (en)
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10573707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL77694(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IL77694A publication Critical patent/IL77694A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL77694A 1985-01-31 1986-01-23 Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging IL77694A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858502399A GB8502399D0 (en) 1985-01-31 1985-01-31 Canine parvovirus vaccines

Publications (1)

Publication Number Publication Date
IL77694A true IL77694A (en) 1992-06-21

Family

ID=10573707

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77694A IL77694A (en) 1985-01-31 1986-01-23 Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging

Country Status (16)

Country Link
US (2) US4810494A (fi)
EP (1) EP0189958B1 (fi)
JP (1) JPH07112982B2 (fi)
CN (1) CN1022801C (fi)
AT (1) ATE47524T1 (fi)
AU (1) AU592786B2 (fi)
CA (1) CA1278513C (fi)
DE (1) DE3666529D1 (fi)
DK (1) DK162421C (fi)
ES (1) ES8706030A1 (fi)
FI (1) FI85222C (fi)
GB (1) GB8502399D0 (fi)
IE (1) IE58357B1 (fi)
IL (1) IL77694A (fi)
NZ (1) NZ214984A (fi)
ZA (1) ZA86446B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
ATE98680T1 (de) * 1987-09-28 1994-01-15 Beecham Inc Inaktivierung von viren und bakterien.
WO1991002054A1 (en) * 1989-08-08 1991-02-21 Arthur Webster Pty. Ltd. Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
AU633349B2 (en) * 1989-08-08 1993-01-28 Fort Dodge Australia Pty Limited Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US6063385A (en) * 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
JP2006515024A (ja) * 2003-01-29 2006-05-18 ファイザー・プロダクツ・インク Ｂｏｒｄｅｔｅｌｌａｂｒｏｎｃｈｉｓｅｐｔｉｃａに対するイヌワクチン
US20050266027A1 (en) * 2004-05-25 2005-12-01 Watson James B Live organism product
US8802171B2 (en) * 2004-05-25 2014-08-12 James B. Watson Live organism product
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
NZ599585A (en) * 2007-06-14 2013-12-20 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
JP6200155B2 (ja) * 2010-03-05 2017-09-20 インターベット インターナショナル ベー． フェー． 組換え弱毒化パルボウイルス
CN101942419B (zh) * 2010-07-30 2012-08-22 中国农业科学院哈尔滨兽医研究所 犬细小病毒弱毒疫苗株及其应用
WO2012164372A1 (en) 2011-06-01 2012-12-06 Indian Immunologicals Limited Recombinant anti-canine parvovirus antibody and uses thereof
CN106591242B (zh) * 2016-11-18 2019-08-30 北京世纪元亨动物防疫技术有限公司 一株犬细小病毒毒株cpv-yh及其应用
CN109735505A (zh) * 2018-12-26 2019-05-10 河南农业大学 一株犬细小病毒毒株及其基因序列的扩增和应用
CN110859956B (zh) * 2019-11-07 2020-11-20 衡阳师范学院 一种犬细小病毒灭活疫苗及其制备方法
CN113073083B (zh) * 2020-01-03 2022-09-06 普莱柯生物工程股份有限公司 犬细小病毒弱毒株、及其制备的疫苗组合物和应用
CN117106732B (zh) * 2023-09-07 2024-02-06 华中农业大学 一株犬细小病毒及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193991A (en) * 1978-12-20 1980-03-18 Cornell Research Foundation, Inc. Canine parvovirus vaccine
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
EP0117767A1 (en) * 1983-01-07 1984-09-05 Mgi Pharma, Inc. Production of parvovirus subunit vaccines
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines

Also Published As

Publication number Publication date
DK162421C (da) 1992-03-23
JPS61180724A (ja) 1986-08-13
EP0189958A3 (en) 1988-07-06
DK47286A (da) 1986-08-01
ES8706030A1 (es) 1987-06-01
FI85222B (fi) 1991-12-13
JPH07112982B2 (ja) 1995-12-06
NZ214984A (en) 1988-05-30
ATE47524T1 (de) 1989-11-15
US4810494A (en) 1989-03-07
US5316764A (en) 1994-05-31
FI860445A (fi) 1986-08-01
AU5280186A (en) 1986-08-07
IE860168L (en) 1986-07-31
FI860445A0 (fi) 1986-01-30
DK162421B (da) 1991-10-28
CN1022801C (zh) 1993-11-24
CA1278513C (en) 1991-01-02
AU592786B2 (en) 1990-01-25
EP0189958B1 (en) 1989-10-25
ZA86446B (en) 1986-09-24
FI85222C (fi) 1992-03-25
DE3666529D1 (en) 1989-11-30
IE58357B1 (en) 1993-09-08
GB8502399D0 (en) 1985-03-06
ES551461A0 (es) 1987-06-01
DK47286D0 (da) 1986-01-30
CN86100726A (zh) 1986-10-01
EP0189958A2 (en) 1986-08-06

Similar Documents

Publication Publication Date Title
IL77694A (en) Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging
ES8605039A1 (es) Procedimiento para preparar una vacuna que comprende un derivado truncado, libre de una membrana de un tipo fijado a una membrana que tiene determinantes antigenicos expuestos.
DK0500917T3 (da) Vacciner og fremgangsmåder baseret på rekombinante herpes simplex virusser.
ES8500997A1 (es) Un metodo para producir un peptido.
ES8202584A1 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
GR3022850T3 (en) Synthetic DNA derived recombinant HIV-1 antigens
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
FR2600079B1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
DE69941099D1 (de) Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria
WO1988007080A3 (en) Transgenic animal cells resistant to viral infection
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
AU4088299A (en) Novel post-transcriptional regulatory elements and uses thereof
EP0145589A3 (fr) Culture de cellules eucaryotes productrices d'une protéine vaccinante, notamment d'antigène HBs
ES2084587T3 (es) Arn virus no revertientes.
Gates COMPARISON OF CROSS-REACTIVE ANTIGENS IN SINDBIS AND SEMLIKI FOREST VIRIONS AND INFECTED CELLS.
DK135686D0 (da) Polypeptid med en antigen determinant af herpes simplex-virus, detsfremstilling og anvendelse
SU1533329A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed
EXP Patent expired